These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9804374)

  • 1. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.
    Newcomb EW; Cohen H; Lee SR; Bhalla SK; Bloom J; Hayes RL; Miller DC
    Brain Pathol; 1998 Oct; 8(4):655-67. PubMed ID: 9804374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
    Kraus JA; Wenghoefer M; Glesmann N; Mohr S; Beck M; Schmidt MC; Schröder R; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Heuser K; Müller B; Fimmers R; von Deimling A; Schlegel U
    J Neurooncol; 2001 May; 52(3):263-72. PubMed ID: 11519857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme.
    Stark AM; Witzel P; Strege RJ; Hugo HH; Mehdorn HM
    J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):779-83. PubMed ID: 12754350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related expression of p53, Mdm2, EGFR and Msh2 in glioblastoma multiforme.
    Stark AM; Hugo HH; Witzel P; Mihajlovic Z; Mehdorn HM
    Zentralbl Neurochir; 2003; 64(1):30-6. PubMed ID: 12582944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas.
    Sung T; Miller DC; Hayes RL; Alonso M; Yee H; Newcomb EW
    Brain Pathol; 2000 Apr; 10(2):249-59. PubMed ID: 10764044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway.
    Das A; Tan WL; Teo J; Smith DR
    J Neurooncol; 2002 Nov; 60(2):117-25. PubMed ID: 12635658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of radiographically defined de novo glioblastoma multiforme.
    Tortosa A; Ino Y; Odell N; Swilley S; Sasaki H; Louis DN; Henson JW
    Neuropathol Appl Neurobiol; 2000 Dec; 26(6):544-52. PubMed ID: 11123721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
    Khatri RG; Navaratne K; Weil RJ
    J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supratentorial glioblastoma in adults: identification of subsets and their clinical correlation.
    Sarkar C; Sinha S; Sharma MC; Kumar R; Mehta VS
    Brain Tumor Pathol; 2004; 21(1):7-12. PubMed ID: 15696962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status.
    Halatsch ME; Schmidt U; Unterberg A; Vougioukas VI
    Anticancer Res; 2006; 26(6B):4191-4. PubMed ID: 17201132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of MGMT methylation and expression of MGMT, P53, EGFR, MDM2 and PTEN in glioblastoma multiforme.
    Limam S; Missaoui N; Abdessayed N; Mestiri S; Selmi B; Mokni M; Yacoubi MT
    Ann Biol Clin (Paris); 2019 Jun; 77(3):307-317. PubMed ID: 31131831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.
    Kraus JA; Glesmann N; Beck M; Krex D; Klockgether T; Schackert G; Schlegel U
    J Neurooncol; 2000 Jun; 48(2):89-94. PubMed ID: 11083071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
    Burton EC; Lamborn KR; Forsyth P; Scott J; O'Campo J; Uyehara-Lock J; Prados M; Berger M; Passe S; Uhm J; O'Neill BP; Jenkins RB; Aldape KD
    Clin Cancer Res; 2002 Jan; 8(1):180-7. PubMed ID: 11801556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and secondary glioblastomas: from concept to clinical diagnosis.
    Kleihues P; Ohgaki H
    Neuro Oncol; 1999 Jan; 1(1):44-51. PubMed ID: 11550301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
    Ruano Y; Ribalta T; de Lope AR; Campos-Martín Y; Fiaño C; Pérez-Magán E; Hernández-Moneo JL; Mollejo M; Meléndez B
    Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
    Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H
    Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma.
    Ushio Y; Tada K; Shiraishi S; Kamiryo T; Shinojima N; Kochi M; Saya H
    Front Biosci; 2003 May; 8():e281-8. PubMed ID: 12700122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
    Simmons ML; Lamborn KR; Takahashi M; Chen P; Israel MA; Berger MS; Godfrey T; Nigro J; Prados M; Chang S; Barker FG; Aldape K
    Cancer Res; 2001 Feb; 61(3):1122-8. PubMed ID: 11221842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line.
    Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
    Anticancer Res; 2001; 21(1A):189-95. PubMed ID: 11299733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
    Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.